001     144847
005     20240229112639.0
024 7 _ |a 10.18632/oncotarget.27198
|2 doi
024 7 _ |a pmid:31534634
|2 pmid
024 7 _ |a pmc:PMC6739213
|2 pmc
037 _ _ |a DKFZ-2019-02271
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Chretien, Anne-Sophie
|b 0
245 _ _ |a Correction: NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia.
260 _ _ |a [S.l.]
|c 2019
|b Impact Journals LLC
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1569222351_11274
|2 PUB:(DE-HGF)
|x Erratum/Correction
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a [This corrects the article DOI: 10.18632/oncotarget.17747.].
536 _ _ |a 314 - Tumor immunology (POF3-314)
|0 G:(DE-HGF)POF3-314
|c POF3-314
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Fauriat, Cyril
|b 1
700 1 _ |a Orlanducci, Florence
|b 2
700 1 _ |a Rey, Jerome
|b 3
700 1 _ |a Borg, Gaelle Bouvier
|b 4
700 1 _ |a Gautherot, Emmanuel
|b 5
700 1 _ |a Granjeaud, Samuel
|b 6
700 1 _ |a Demerle, Clemence
|b 7
700 1 _ |a Hamel, Jean-François
|b 8
700 1 _ |a Cerwenka, Adelheid
|0 P:(DE-He78)d2b4dd8bdffe4aaa0f5e30e91587766f
|b 9
|u dkfz
700 1 _ |a von Strandmann, Elke Pogge
|b 10
700 1 _ |a Ifrah, Norbert
|b 11
700 1 _ |a Lacombe, Catherine
|b 12
700 1 _ |a Cornillet-Lefebvre, Pascale
|b 13
700 1 _ |a Delaunay, Jacques
|b 14
700 1 _ |a Toubert, Antoine
|b 15
700 1 _ |a Arnoulet, Christine
|b 16
700 1 _ |a Vey, Norbert
|b 17
700 1 _ |a Olive, Daniel
|b 18
773 _ _ |a 10.18632/oncotarget.27198
|g Vol. 10, no. 52
|0 PERI:(DE-600)2560162-3
|n 52
|p 5493
|t OncoTarget
|v 10
|y 2019
|x 1949-2553
909 C O |o oai:inrepo02.dkfz.de:144847
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)d2b4dd8bdffe4aaa0f5e30e91587766f
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-314
|2 G:(DE-HGF)POF3-300
|v Tumor immunology
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2019
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
920 1 _ |0 I:(DE-He78)D080-20160331
|k D080
|l Nachwuchsgruppe Angeborene Immunität
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)D080-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21